Gut microbiota and diabetes: from pathogenesis to therapeutic perspective

Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A et al (2009) The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis. Acta Diabetol 46(2):145–154

Danaei G, Lawes CM, Vander Hoorn S, Murray CJ, Ezzati M (2006) Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet 368(9548):1651–1659

WHO (2004) Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. WHO, Geneva

Ruchat SM, Elks CE, Loos RJ, Vohl MC, Weisnagel SJ, Rankinen T et al (2009) Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies. Acta Diabetol 46(3):217–226

Amann RI, Zarda B, Stahl DA, Schleifer KH (1992) Identification of individual prokaryotic cells by using enzyme-labeled, rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 58(9):3007–3011

Goodman AL, Kallstrom G, Faith JJ, Reyes A, Moore A, Dantas G et al (2011) Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci USA 108(15):6252–6257

Knights D, Costello E, Knight R (2010) Supervised classication of human microbiota. FEMS Microbiol Rev 35:343–359

Dethlefsen L, Eckburg PB, Bik EM, Relman DA (2006) Assembly of the human intestinal microbiota. Trends Ecol Evol 21(9):517–523

Dethlefsen L, McFall-Ngai M, Relman DA (2007) An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449(7164):811–818

Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI (2007) The human microbiome project. Nature 449(7164):804–810

Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59–65

Mackie RI, Sghir A, Gaskins HR (1999) Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 69(5):1035S–1045S

Favier CF, Vaughan EE, De Vos WM, Akkermans AD (2002) Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 68(1):219–226

Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO (2007) Development of the human infant intestinal microbiota. PLoS Biol 5(7):e177

Zoetendal EG, Rajilic-Stojanovic M, de Vos WM (2008) High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57(11):1605–1615

Claesson MJ, Cusack S, O’Sullivan O, Greene-Diniz R, de Weerd H, Flannery E et al (2011) Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 108(Suppl 1):4586–4591

Zoetendal EG, Akkermans AD, De Vos WM (1998) Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 64(10):3854–3859

Tap J, Mondot S, Levenez F, Pelletier E, Caron C, Furet JP et al (2009) Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 11(10):2574–2584

Ley RE, Peterson DA, Gordon JI (2006) Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124(4):837–848

Wells JM, Rossi O, Meijerink M, van Baarlen P (2011) Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci USA 108(Suppl 1):4607–4614

Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC (2008) The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA 105(39):15064–15069

Asquith MT, Harrod JR (1979) Reduction of bacterial contamination in banked human milk. J Pediatr 95(6):993–994

Rotimi VO, Olowe SA, Ahmed I (1985) The development of bacterial flora of premature neonates. J Hyg (Lond) 94(3):309–318

Kalliomaki M, Collado MC, Salminen S, Isolauri E (2008) Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 87(3):534–538

Manichanh C, Reeder J, Gibert P, Varela E, Llopis M, Antolin M et al (2010) Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res 20(10):1411–1419

Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, Mulder I, Lan A, Bridonneau C et al (2009) The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31(4):677–689

Hapfelmeier S, Lawson MA, Slack E, Kirundi JK, Stoel M, Heikenwalder M et al (2010) Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 328(5986):1705–1709

Cerutti A, Rescigno M (2008) The biology of intestinal immunoglobulin A responses. Immunity 28(6):740–750

Cerutti A (2010) Immunology. IgA changes the rules of memory. Science 328(5986):1646–1647

Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Human gut microbes associated with obesity. Nature 444:1022–1023

Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK et al (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5(2):e9085

Serino M, Luche E, Chabo C, Amar J, Burcelin R (2009) Intestinal microflora and metabolic diseases. Diabetes Metab 35(4):262–272

Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS et al (2008) Evolution of mammals and their gut microbes. Science 320(5883):1647–1651

Sonnenburg ED, Zheng H, Joglekar P, Higginbottom SK, Firbank SJ, Bolam DN et al (2010) Specificity of polysaccharide use in intestinal Bacteroides species determines diet-induced microbiota alterations. Cell 141(7):1241–1252

Shoelson S, Lee J, Goldfine A (2006) Inflammation and insulin resistance. J Clin Invest 116:1793–1801

Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444(7121):860–867

Ooi LG, Ahmad R, Yuen KH, Liong MT (2010) Lactobacillus acidophilus CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters. J Dairy Sci 93(11):5048–5058

Ley R, Hamady M, Lozupone C, Turnbaugh P, Ramey R, Bircher J et al (2008) Evolution of mammals and their gut microbes. Science 320:1647–1651

Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host-bacterial mutualism in the human intestine. Science 307(5717):1915–1920

Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A et al (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101(44):15718–15723

Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102(31):11070–11075

Baker GC, Smith JJ, Cowan DA (2003) Review and re-analysis of domain-specific 16S primers. J Microbiol Methods 55(3):541–555

Neefs JM, Van de Peer Y, De Rijk P, Chapelle S, De Wachter R (1993) Compilation of small ribosomal subunit RNA structures. Nucleic Acids Res 21(13):3025–3049

Wang Q, Garrity G, Tiedje J, Cole J (2007) Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73:5261–5267

von Mering C, Jensen LJ, Snel B, Hooper SD, Krupp M, Foglierini M et al (2005) STRING: known and predicted protein–protein associations, integrated and transferred across organisms. Nucleic Acids Res 33(Database issue):D433–D437

Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M (2004) The KEGG resource for deciphering the genome. Nucleic Acids Res 32(Database issue):D277–D280

Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122):1027–1031

Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE et al (2009) A core gut microbiome in obese and lean twins. Nature 457(7228):480–484

Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ et al (2011) Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci USA 108(Suppl 1):4516–4522

Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K et al (2004) Bariatric surgery: a systematic review and meta-analysis. Jama 292(14):1724–1737

Nishizawa Y, Imaizumi T, Tanishita H, Yano I, Kawai Y, Mormii H (1988) Relationship of fat deposition and intestinal microflora in VMH rats. Int J Obes 12(2):103–110

Heijtz RD, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A et al (2011) Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 108(7):3047–3052

Wen L, Ley R, Volchkov P, Stranges P, Avanesyan L, Stonebraker A et al (2008) Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455(7216):1109–1113

Hooper LV, Stappenbeck TS, Hong CV, Gordon JI (2003) Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 4(3):269–273

Hooper LV, Gordon JI (2001) Commensal host-bacterial relationships in the gut. Science 292(5519):1115–1118

Bry L, Falk PG, Midtvedt T, Gordon JI (1996) A model of host-microbial interactions in an open mammalian ecosystem. Science 273(5280):1380–1383

Schenk M, Mueller C (2008) The mucosal immune system at the gastrointestinal barrier. Best Pract Res Clin Gastroenterol 22(3):391–409

Pickup JC, Crook MA (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41(10):1241–1248

Cani PD, Delzenne NM, Amar J, Burcelin R (2008) Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding. Pathol Biol (Paris) 56(5):305–309

Turnbaugh P, Ridaura V, Faith J, Rey F, Knight R, Gordon J (2009) The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1:6–14

Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM et al (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57(6):1470–1481

Bukoff M, Carlson S (1981) Diet modifications and behavioral changes for bariatric gastric surgery. J Am Diet Assoc 78(2):158–161

Edwards CM, Todd JF, Mahmoudi M, Wang Z, Wang RM, Ghatei MA et al (1999) Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9–39. Diabetes 48(1):86–93

Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y et al (2009) Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 106(7):2365–2370

Calvani R, Miccheli A, Capuani G, Tomassini Miccheli A, Puccetti C, Delfini M et al (2010) Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. Int J Obes (Lond) 34(6):1095–1098

Backhed F, Manchester JK, Semenkovich CF, Gordon JI (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 104(3):979–984

Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A et al (2006) Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 103(33):12511–12516

Spencer M, Hamp T, Reid R, Fischer L, Zeisel S, Fodor A (2011) Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 140(3):976–986

Murphy EF, Cotter PD, Healy S, Marques TM, O’Sullivan O, Fouhy F et al (2010) Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 59(12):1635–1642

Caspar-Bauguil S, Cousin B, Galinier A, Segafredo C, Nibbelink M, Andre M et al (2005) Adipose tissues as an ancestral immune organ: site-specific change in obesity. FEBS Lett 579(17):3487–3492

Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A et al (2009) Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15:930–939

Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112(12):1796–1808

Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J et al (2009) Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 15(8):921–929

Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118(2):229–241

Fritz JH, Le Bourhis L, Sellge G, Magalhaes JG, Fsihi H, Kufer TA et al (2007) Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 26(4):445–459

Kufer TA, Sansonetti PJ (2007) Sensing of bacteria: NOD a lonely job. Curr Opin Microbiol 10(1):62–69

Amar J, Burcelin R, Ruidavets J, Cani P, Fauvel J, Alessi M et al (2008) Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 87:1219–1223

Poggi M, Bastelica D, Gual P, Iglesias MA, Gremeaux T, Knauf C et al (2007) C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 50(6):1267–1276

Song MJ, Kim KH, Yoon JM, Kim JB (2006) Activation of toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 346(3):739–745

Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock NM, Magness S et al (2010) High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 5(8):e12191

Membrez M, Blancher F, Jaquet M, Bibiloni R, Cani PD, Burcelin RG et al (2008) Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. Faseb J 22(7):2416–2426

Laugerette F, Vors C, Geloen A, Chauvin MA, Soulage C, Lambert-Porcheron S et al (2010) Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutr Biochem 22(1):53–59

Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O et al (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58(8):1091–1103

Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S et al (2010) Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science 328(5975):228–231

Black DD, Tso P, Weidman S, Sabesin SM (1983) Intestinal lipoproteins in the rat with D-(+)-galactosamine hepatitis. J Lipid Res 24(8):977–992

Pappo I, Becovier H, Berry EM, Freund HR (1991) Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat. J Surg Res 51(2):106–112

Harris HW, Brady SE, Rapp JH (2002) Hepatic endosomal trafficking of lipoprotein-bound endotoxin in rats. J Surg Res 106(1):188–195

Ghoshal S, Witta J, Zhong J, de Villiers W, Eckhardt E (2009) Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 50(1):90–97

Rensen PC, Oosten M, Bilt E, Eck M, Kuiper J, Berkel TJ (1997) Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats in vivo. J Clin Invest 99(10):2438–2445

Westerterp M, Berbee JF, Pires NM, van Mierlo GJ, Kleemann R, Romijn JA et al (2007) Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice. Circulation 116(19):2173–2181

Thabut D, Tazi KA, Bonnefont-Rousselot D, Aller M, Farges O, Guimont MC et al (2007) High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats. Hepatology 46(6):1893–1906

Vreugdenhil AC, Rousseau CH, Hartung T, Greve JW, van ‘t Veer C, Buurman WA (2003) Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. J Immunol 170(3):1399–1405

Velagapudi VR, Hezaveh R, Reigstad CS, Gopalacharyulu P, Yetukuri L, Islam S et al (2010) The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res 51(5):1101–1112

Gustafsson BE, Einarsson K, Gustafsson J (1975) Influence of cholesterol feeding on liver microsomal metabolism of steroids and bile acids in conventional and germ-free rats. J Biol Chem 250(21):8496–8502

Gerard P, Lepercq P, Leclerc M, Gavini F, Raibaud P, Juste C (2007) Bacteroides sp. strain D8, the first cholesterol-reducing bacterium isolated from human feces. Appl Environ Microbiol 73:5742–5749

Oresic M, Seppanen-Laakso T, Yetukuri L, Backhed F, Hanninen V (2009) Gut microbiota affects lens and retinal lipid composition. Exp Eye Res 89(5):604–607

Caesar R, Fak F, Backhed F (2010) Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med 268(4):320–328

Ott S, El Mokhtari N, Musfeldt M (2006) Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 113:929–937

Koren O, Spor A, Felin J, Fak F, Stombaugh J, Tremaroli V et al (2011) Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci USA 108(Suppl 1):4592–4598

Maziere C, Conte MA, Dantin F, Maziere JC (1999) Lipopolysaccharide enhances oxidative modification of low density lipoprotein by copper ions, endothelial and smooth muscle cells. Atherosclerosis 143(1):75–80

Amar J, Ruidavets JB, Bal Dit Sollier C, Bongard V, Boccalon H, Chamontin B et al (2003) Soluble CD14 and aortic stiffness in a population-based study. J Hypertens 21(10):1869–1877

Kocaman SA, Sahinarslan A, Akyel A, Timurkaynak T, Boyaci B, Cengel A (2010) The association of circulating monocyte count with coronary collateral growth in patients with diabetes mellitus. Acta Diabetol 47(1):49–54

Dalmasso G, Nguyen HT, Yan Y, Laroui H, Charania MA, Ayyadurai S et al (2011) Microbiota modulate host gene expression via microRNAs. PLoS One 6(4):e19293

Menghini R, Casagrande V, Cardellini M, Martelli E, Terrinoni A, Amati F et al (2009) MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120(15):1524–1532

Ferre P, Foufelle F (2010) Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab Suppl 2:83–92

Postic C, Girard J (2008) The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab 34(6 Pt 2):643–648

Day CP (2010) Genetic and environmental susceptibility to non-alcoholic fatty liver disease. Dig Dis 28(1):255–260

Han DW (2002) Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol 8(6):961–965

Zhang HY, de Han W, Su AR, Zhang LT, Zhao ZF, Ji JQ et al (2007) Intestinal endotoxemia plays a central role in development of hepatopulmonary syndrome in a cirrhotic rat model induced by multiple pathogenic factors. World J Gastroenterol 13(47):6385–6395

Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA (2003) Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37(5):1043–1055

Assan R, Feutren G, Sirmai J, Laborie C, Boitard C, Vexiau P et al (1990) Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin. Diabetes 39:768–774

Burcelin RG, Eddouks M, Beylot M, Normand S, Boitard C, Feutren G et al (1993) Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients. Diabetes Care 16(6):881–888

King C, Sarvetnick N (2011) The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLoS One 6(2):e17049

Pozzilli P, Signore A, Williams AJ, Beales PE (1993) NOD mouse colonies around the world—recent facts and figures. Immunol Today 14(5):193–196

McInerney MF, Pek SB, Thomas DW (1991) Prevention of insulitis and diabetes onset by treatment with complete Freund’s adjuvant in NOD mice. Diabetes 40(6):715–725

Sadelain MW, Qin HY, Lauzon J, Singh B (1990) Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39(5):583–589

Patterson CC, Dahlquist G, Soltesz G, Green A (2001) Is childhood-onset type I diabetes a wealth-related disease? An ecological analysis of European incidence rates. Diabetologia 44(Suppl 3):B9–B16

Levy-Marchal C, Patterson CC, Green A (2001) Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and dibetes. Diabetologia 44(Suppl 3):B75–B80

Green A, Patterson CC (2001) Trends in the incidence of childhood-onset diabetes in Europe 1989–1998. Diabetologia 44(Suppl 3):B3–B8

Holt PG, Somerville C, Baron-Hay MJ, Holt BJ, Sly PD (1995) Functional assessment of CD2, CD3 and CD28 on the surface of peripheral blood T-cells from infants at low versus high genetic risk for atopy. Pediatr Allergy Immunol 6(2):80–84

Holt PG (1995) Postnatal maturation of immune competence during infancy and childhood. Pediatr Allergy Immunol 6(2):59–70

Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124(4):783–801

Valladares R, Sankar D, Li N, Williams E, Lai KK, Abdelgeliel AS et al (2010) Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One 5(5):e10507

Brugman S, Klatter FA, Visser JT, Wildeboer-Veloo AC, Harmsen HJ, Rozing J et al (2006) Antibiotic treatment partially protects against type 1 diabetes in the bio-breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49(9):2105–2108

Pischon T, Hu F, Rexrode K, Girman C, Manson J, Rimm E (2008) Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis 197:392–399

Firatli E (1997) The relationship between clinical periodontal status and insulin-dependent diabetes mellitus. Results after 5 years. J Periodontol 68:136–140

D’Aiuto F, Sabbah W, Netuveli G, Donos N, Hingorani A, Deanfield J (2008) Association of the metabolic syndrome with severe periodontitis in a large US population-based survey. J Clin Endocrinol Metab 93:3989–3994

Vergnes JN, Kaminski M, Lelong N, Musset AM, Sixou M, Nabet C (2011) Maternal dental caries and pre-term birth: results from the EPIPAP study. Acta Odontol Scand 69(4):248–256

Löe H (1993) Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 16(1):329–334

Soell M, Hassan M, Miliauskaite A, Haïkel Y, Selimovic D (2007) The oral cavity of elderly patients in diabetes. Diabetes Metab 33(Suppl 1):S10–S18

Slots J (1986) Rapid identification of important periodontal microorganisms by cultivation. Oral Microbiol Immunol 1:48–57

Doan N, Contreras A, Flynn J, Morrison J, Slots J (1999) Proficiencies of three anaerobic culture systems for recovering periodontal pathogenic bacteria. J Clin Microbiol 37:171–174

Saito T, Shimazaki Y (2007) Metabolic disorders related to obesity and periodontal disease. Periodontology 43:254–266

Hettne K, Weeber M, Laine M, Ten Cate H, Boyer S, Kors J (2007) Automatic mining of the literature to generate new hypotheses for the possible link between periodontitis and atherosclerosis: lipopolysaccharide as a case study. J Clin Periodontol 34:1016–1024

Darré L, Vergnes J-N, Gourdy P, Sixou M (2008) Efficacy of periodontal treatment on glycaemic control in diabetic patients: a meta-analysis of interventional studies. Diabetes Metab 34:497–506

Grossi S (2001) Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research. Ann Periodontol 6:138–145

Miller L, Manwell M, Newbold D, Reding M, Rasheed A, Blodgett J (1992) The relationship between reduction in periodontal inflammation and diabetes control: a report of 9 cases. J Periodontol 63:843–848

Roberfroid M (2007) Prebiotics: the concept revisited. J Nutr 137(3 Suppl 2):830S–837S

Roberfroid MB (2007) Inulin-type fructans: functional food ingredients. J Nutr 137(11 Suppl):2493S–2502S

Gibson GR (1998) Dietary modulation of the human gut microflora using prebiotics. Br J Nutr 80(4):S209–S212

Guarner F (2007) Studies with inulin-type fructans on intestinal infections, permeability, and inflammation. J Nutr 137:2568S–2571S

Cani PD, Neyrinck AM, Maton N, Delzenne NM (2005) Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide-1. Obes Res 13(6):1000–1007

Knauf C, Cani PD, Kim DH, Iglesias MA, Chabo C, Waget A et al (2008) Role of central nervous system glucagon-like peptide-1 receptors in enteric glucose sensing. Diabetes 57(10):2603–2612

Boirivant M, Strober W (2007) The mechanism of action of probiotics. Curr Opin Gastroenterol 23(6):679–692

Collado MC, Meriluoto J, Salminen S (2007) Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett Appl Microbiol 45(4):454–460

Fukushima Y, Kawata Y, Mizumachi K, Kurisaki J, Mitsuoka T (1999) Effect of bifidobacteria feeding on fecal flora and production of immunoglobulins in lactating mouse. Int J Food Microbiol 46(3):193–197

McCarthy J, O’Mahony L, O’Callaghan L, Sheil B, Vaughan EE, Fitzsimons N et al (2003) Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52(7):975–980

Menard S, Candalh C, Bambou JC, Terpend K, Cerf-Bensussan N, Heyman M (2004) Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 53(6):821–828

Osman N, Adawi D, Molin G, Ahrne S, Berggren A, Jeppsson B (2006) Bifidobacterium infantis strains with and without a combination of oligofructose and inulin (OFI) attenuate inflammation in DSS-induced colitis in rats. BMC Gastroenterol 6:31

Trevisi P, De Filippi S, Minieri L, Mazzoni M, Modesto M, Biavati B et al (2008) Effect of fructo-oligosaccharides and different doses of Bifidobacterium animalis in a weaning diet on bacterial translocation and toll-like receptor gene expression in pigs. Nutrition 24(10):1023–1029

Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K et al (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469(7331):543–547

Mazmanian SK, Round JL, Kasper DL (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453(7195):620–625

Kondo S, Xiao J, Satoh T, Odamaki T, Takahashi S, Sugahara H et al (2010) Antiobesity effects of bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Biosci Biotechnol Biochem 74(8):1656–1661

Velayudham A, Dolganiuc A, Ellis M, Petrasek J, Kodys K, Mandrekar P et al (2009) VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology 49:989–997

Medina J, Fernandez-salazar L, Garcia-Buey L, Moreno-Otero R (2004) Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care 27:2057–2066

Esposito E, Iacono A, Bianco G, Autore G, Cuzzocrea S, Vajro P et al (2009) Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J Nutr 139:905–911

Andreasen A, Larsen N, Pedersen-Skovsgaard M, Møller M, Svendsen K, Jakobsen M et al (2010) Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 104(12):1831–1838

Laitinen K, Poussa T, Isolauri E, Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota Group (2009) Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr 101:1679–1687